Resolution metabolomes activated by hypoxic environment
暂无分享,去创建一个
[1] A. Iolascon,et al. Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. , 2019, Blood.
[2] M. Basha,et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia , 2019, Journal of the Practice of Cardiovascular Sciences.
[3] Yao Lu,et al. Hemin impairs resolution of inflammation via microRNA‐144‐3p‐dependent downregulation of ALX/FPR2 , 2018, Transfusion.
[4] M. Bäck,et al. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease , 2018, Front. Pharmacol..
[5] J. Bowser,et al. Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation. , 2018, JCI insight.
[6] L. Joosten,et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation , 2018, Nature Immunology.
[7] G. Hansmann,et al. Inhibition of neogenin fosters resolution of inflammation and tissue regeneration , 2018, The Journal of clinical investigation.
[8] S. Shuto,et al. Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice. , 2018, Journal of pharmacological sciences.
[9] W. Seeger,et al. Resolvin E1 and its precursor 18R-HEPE restore mitochondrial function in inflammation. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[10] Aldert L. Zomer,et al. Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation , 2018, EBioMedicine.
[11] C. Serhan,et al. Splenic leukocytes define the resolution of inflammation in heart failure , 2018, Science Signaling.
[12] Ivana V. Yang,et al. Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury , 2018, Nature Communications.
[13] J. C. Love,et al. Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage , 2017, The Journal of clinical investigation.
[14] O. Werz,et al. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity , 2018, Nature Communications.
[15] C. Taylor,et al. Regulation of immunity and inflammation by hypoxia in immunological niches , 2017, Nature Reviews Immunology.
[16] T. Standiford,et al. Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice , 2017, Science Translational Medicine.
[17] W. Harris,et al. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. , 2017, Journal of clinical lipidology.
[18] P. Carmeliet,et al. Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses , 2017, The Journal of clinical investigation.
[19] C. Serhan,et al. A cluster of immunoresolvents links coagulation to innate host defense in human blood , 2017, Science Signaling.
[20] W. Harris,et al. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. , 2017, Atherosclerosis.
[21] M. Perretti,et al. The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1 , 2017, The Journal of Biological Chemistry.
[22] Frank Buttgereit,et al. Metabolic regulation of inflammation , 2017, Nature Reviews Rheumatology.
[23] S. Colgan,et al. Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. , 2017, Molecular aspects of medicine.
[24] David M. Jones,et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques , 2016, Nature Communications.
[25] Yuzhang Wu,et al. Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution , 2016, Nature Communications.
[26] R. Keep,et al. Hematoma Changes During Clot Resolution After Experimental Intracerebral Hemorrhage , 2016, Stroke.
[27] G. Fredman,et al. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation , 2016, Proceedings of the National Academy of Sciences.
[28] E. Mills,et al. Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal , 2016, European journal of immunology.
[29] M. Prentki,et al. Simplified assays of lipolysis enzymes for drug discovery and specificity assessment of known inhibitors , 2016, Journal of Lipid Research.
[30] D. Zeldin,et al. Resolvin Infectious Inflammation by Targeting the Host Response. , 2015, The New England journal of medicine.
[31] T. Mori,et al. Effects of omega-3 and omega-6 fatty acids on human placental cytokine production. , 2015, Placenta.
[32] S. Schlager,et al. Adipose triglyceride lipase regulates eicosanoid production in activated human mast cells , 2014, Journal of Lipid Research.
[33] J. Backs,et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway , 2014, Proceedings of the National Academy of Sciences.
[34] M. Arita,et al. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] C. Glass,et al. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation , 2014, Proceedings of the National Academy of Sciences.
[36] C. Serhan,et al. Cutting Edge: Parathyroid Hormone Facilitates Macrophage Efferocytosis in Bone Marrow via Proresolving Mediators Resolvin D1 and Resolvin D2 , 2014, The Journal of Immunology.
[37] C. Serhan,et al. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.
[38] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[39] S. McKeown,et al. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. , 2014, The British journal of radiology.
[40] R. Nemenoff,et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.
[41] Philip A. Kramer,et al. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: Implications for their use as bioenergetic biomarkers , 2014, Redox biology.
[42] Christoph H. Borchers,et al. HIF1A Reduces Acute Lung Injury by Optimizing Carbohydrate Metabolism in the Alveolar Epithelium , 2013, PLoS biology.
[43] M. Gelb,et al. Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators , 2013, The Journal of experimental medicine.
[44] M. Arita,et al. Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3. , 2013, Journal of biochemistry.
[45] C. Serhan,et al. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.
[46] E. Clambey,et al. Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa , 2012, Proceedings of the National Academy of Sciences.
[47] J. Wallace,et al. Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe , 2012, Scientific Reports.
[48] Sriram Krishnamoorthy,et al. MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] H. Eltzschig. Targeting Hypoxia-induced Inflammation. , 2011, Anesthesiology.
[50] C. Serhan,et al. Resolvin E1 Regulates Adenosine Diphosphate Activation of Human Platelets , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[51] I. Tabas. Macrophage death and defective inflammation resolution in atherosclerosis , 2010, Nature Reviews Immunology.
[52] F. D’Acquisto,et al. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation , 2009, Nature Reviews Immunology.
[53] C. Dinarello. Historical insights into cytokines , 2007, European journal of immunology.
[54] Lois E. H. Smith,et al. Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.
[55] Charles N. Serhan,et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.
[56] Katherine B Percarpio,et al. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.
[57] S. Prescott,et al. Fish oil fix , 2005, Nature Medicine.
[58] M. Sitkovsky,et al. Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.
[59] T. Shimizu,et al. An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[60] G. Majno,et al. Cells, tissues, and disease : principles of general pathology , 1996 .
[61] G. Semenza,et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.
[62] A. Stern,et al. Human red cells enhance the formation of 5-lipoxygenase-derived products by neutrophils. , 1989, Free radical research communications.
[63] S. Dahlén,et al. Leukotriene B4 induces extravasation and migration of polymorphonuclear leukocytes in vivo. , 1982, Acta physiologica Scandinavica.
[64] S. Kalsner. The effect of hypoxia on prostaglandin output and on tone in isolated coronary arteries. , 1977, Canadian journal of physiology and pharmacology.
[65] S. Shohet,et al. Stages in the incorporation of fatty acids into red blood cells. , 1968, The Journal of clinical investigation.